425: Strive CEO Updates on Semler Scientific Merger

Strive, Inc. CEO Matthew Cole posted an update on X.com regarding the proposed business combination with Semler Scientific, Inc., including cautionary forward-looking statements.

Summary

• Strive, Inc. CEO Matthew Cole posted a communication on X.com on December 29, 2025, concerning the proposed business combination with Semler Scientific, Inc.
• The communication includes cautionary forward-looking statements regarding the proposed transaction, its strategic and financial benefits, timing, and integration.
• The filing emphasizes that actual results could differ materially from anticipated results due to various inherent risks and uncertainties.
• Strive has filed a Registration Statement on Form S-4, which includes an Information Statement/Proxy Statement/Prospectus, with the SEC to register Class A common stock to be issued in connection with the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and other relevant documents filed with the SEC before making any voting or investment decisions.

Sentiment

Score: 5

Explanation: The filing is a standard legal disclosure for a merger communication, heavily emphasizing forward-looking statements and a comprehensive list of risks. While the underlying event (merger) is significant, the document itself is neutral to cautious, focusing on compliance and potential challenges rather than positive outcomes.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.

Negatives

• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Potential adverse reactions from customers or changes to business or employee relationships could occur.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, the implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact results.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors also could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The proposed transaction is expected to result in strategic and financial benefits for the combined company, with the timing of the closing and successful integration being key objectives. However, these expectations are subject to various risks and uncertainties, and actual results may differ materially.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, Inc., communicated on X.com on December 29, 2025, regarding the proposed business combination with Semler Scientific, Inc.

Industry Context

The proposed business combination and its associated risks highlight the increasing trend of companies, including those in the medical technology sector like Semler Scientific, exploring and implementing Bitcoin treasury strategies and engaging with other digital assets. This reflects a broader industry movement towards integrating digital assets into corporate financial management, alongside traditional strategic mergers and acquisitions.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a risk factor for the proposed transaction.

Stakeholder Impact

• Shareholders of Strive will experience dilution due to the issuance of additional Class A common stock for the merger.
• Customers and employees of both Strive and Semler Scientific may have adverse reactions or changes to their relationships due to the announcement or completion of the proposed transaction.

Next Steps

• Strive and Semler Scientific may file other relevant documents concerning the proposed transaction with the SEC.
• A definitive Information Statement/Proxy Statement/Prospectus was sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus before making voting or investment decisions.

Key Dates

Keywords

Merger, Acquisition, Business Combination, Strive Inc., Semler Scientific Inc., SEC Filing, Form 425, Bitcoin, Digital Assets, Corporate Governance, Forward-Looking Statements